אנטרסטו 200 מ"ג - Entresto 200 mg

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×§×××¦× ×¤×¨××§××××××ª (ATC4)

C09DX
Angiotensin II antagonists, other combinations

××¨××× ×¤×¢×× (ATC5)

Sacubitril/valsartan AS SODIUM SALT COMPLEX 97/103MG âC09DX04

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

EntrestoTM is indicated for the treatment of heart failure (NYHA class II-IV) in patients with systolic dysfunction. EntrestoTM has been shown to reduce the rate of cardiovascular death and heart failure hospitalisation compared to angiotensin converting enzyme (ACE) inhibitor therapy

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

12/01/2017

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª
×. ××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××× ×¡×¤××§×ª ×× ××¨×× ××ª ××××× ××¢×× × ×¢× ×× ×××: 1. ×× ×¡×¤××§×ª ×× ×¡××¡×××××ª; 2.××¨××ª ×ª×¤×§×× II-IV ××¤× NYHA; 3. ×¤×× ×× ×§×¨×××× ×× ××¢× 30 ×"×/××§×; 4. ××××¤× ×××©×× ×©× ×ª×¨××¤××ª ××©×ª× ×××©×¤×××ª ×××××ª - ×××¡×× ACE / ARB, ××××¡×× ×××. ×. ××ª× ××××¤×× ××ª×¨××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ××§×¨×××××××× ×× ××××× ××¨×¤××× ×¤× ××××ª ×× ××××× ××¨×¤×××ª ×××©×¤××.	19/02/2025	×× ×××× ××		×× ×¡×¤××§×ª ×× ××¨×× ××ª, CHF, Congestive heart failure
×. ××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××× ×¡×¤××§× ×××××ª ××¨×× ××ª ××××× ××¢×× × ×¢× ×× ×××: 1. ×× ×¡×¤××§×ª ×× ×¡××¡×××××ª ×¢× ××§××¢ ×¤×××× ×©××× ×× × ××× ×-35% 2.××¨××ª ×ª×¤×§×× II-IV ××¤× NYHA. 3. ×¤×× ×× ×§×¨×××× ×× ××¢× 30 ×"×/××§× 4. ××××¤× ×××©×× ×©× ×ª×¨××¤××ª ××©×ª× ×××©×¤×××ª ×××××ª - ×××¡×× ACE / ARB, ××××¡×× ×××. ×. ××ª× ××××¤×× ××ª×¨××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ××§×¨×××××××× ×× ××××× ××¨×¤××× ×¤× ××××ª ×× ××××× ××¨×¤×××ª ×××©×¤××.	12/01/2017	×× ×××× ××		×× ×¡×¤××§×ª ×× ××¨×× ××ª, CHF, Congestive heart failure

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××× ×¡×¤××§× ×××××ª ××¨×× ××ª ××××× ××¢×× × ×¢× ×× ×××:
1. ×× ×¡×¤××§×ª ×× ×¡××¡×××××ª
2. ××¨××ª ×ª×¤×§×× II-IV ××¤× NYHA
3. ×¤×× ×× ×§×¨×××× ×× ××¢× 30 ×"×/××§×
4. ××××¤× ×××©×× ×©× ×ª×¨××¤××ª ××©×ª× ×××©×¤×××ª ×××××ª - ×××¡×× ACE / ARB, ××××¡×× ×××
××ª× ××××¤×× ××ª×¨××¤× ×××××¨× ×××¢×©× ××¤× ××¨×©× ×©× ××××× ××§×¨×××××××× ×× ××××× ××¨×¤××× ×¤× ××××ª ×× ××××× ××¨×¤×××ª ×××©×¤××

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 26.10.2020

××××¨× ××¢××× 26.10.2020

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 31.10.2020 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.10.2020 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 31.10.2020

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
Â ×× ××¨×¡×× 200 ×"× ×××××¨ ××©×¨× ×××¨××××ª ×× ××¨×¡×× 200 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	NOVARTIS PHARMA STEIN AG, SWITZERLAND
×©× ××¢× ××¨××©××	NOVARTIS ISRAEL LTD
×¨××©×××	×ª××¨×× ×××©×: 05/2015. ×¨××©××× ××ª××¨××: 12/2015
×ª××¨×× ×¢×××× ×××¨××	14/05/19

השינוי האחרון נעשה בֹ־19 ביולי 2021 ב־10:54

אנטרסטו 200 מ"ג - Entresto 200 mg

ויקיתרופות